Breaking News Instant updates and real-time market news.

SNX

Synnex

$128.67 /

+1.44 (+1.13%)

, ACRS

Aclaris Therapeutics

$1.87 /

+ (+0.00%)

18:26
01/09/20
01/09
18:26
01/09/20
18:26

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Synnex (SNX), up 7.9%. ALSO HIGHER: Aclaris Therapeutics (ACRS), up 24.2% after announcing "positive" results from its Phase 1 trial of ATI-450... Moderna (MRNA), up 20.4% after reporting "positive" safety and immunogenicity Phase 1 data from its CMV vaccine study... Ultragenyx (RARE), up 17.9% after reporting data on Cohort 3 and 2 from study of DTX301... Venus Concept (VERO), up 6% after Oppenheimer initiated coverage on the stock with an Outperform rating... Intuitive Surgical (ISRG), up 2.3% after reporting preliminary Q4 revenue above estimates. DOWN AFTER EARNINGS: KB Home (KBH), down 2%. ALSO LOWER: Portola Pharmaceuticals (PTLA), down 39.4% after announcing preliminary Andexx net revenues for Q4... Sportsman's Warehouse (SPWH), down 16% after providing guidance for Q4 and fiscal 2019... Urban Outfitters (URBN), down 9.7% after reporting holiday sales... GrubHub (GRUB), down 7.8% after Bloomberg said the company isn't running a sale process.

SNX

Synnex

$128.67 /

+1.44 (+1.13%)

ACRS

Aclaris Therapeutics

$1.87 /

+ (+0.00%)

MRNA

Moderna

$18.39 /

+0.42 (+2.34%)

RARE

Ultragenyx

$43.64 /

-1.485 (-3.29%)

VERO

Venus Concept

$5.67 /

+0.76 (+15.48%)

ISRG

Intuitive Surgical

$585.69 /

+4.35 (+0.75%)

KBH

KB Home

$37.06 /

+0.06 (+0.16%)

PTLA

Portola Pharmaceuticals

$24.73 /

+0.74 (+3.08%)

SPWH

Sportsman's Warehouse

$7.97 /

-0.67 (-7.75%)

URBN

Urban Outfitters

$27.69 /

-0.79 (-2.77%)

GRUB

GrubHub

$55.80 /

+1.1 (+2.01%)

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 13

    Jan

  • 13

    Jan

  • 13

    Jan

  • 14

    Jan

  • 23

    Jan

  • 31

    Jul

SNX Synnex
$128.67 /

+1.44 (+1.13%)

12/23/19 Citi
Citi names Amphenol top pick, cuts Celestica to Sell into 'Year of Connectivity'
09/06/19 BofA
Synnex initiated with a Buy at BofA/Merrill
04/12/19 Citi
Synnex price target raised to $140 from $130 at Citi
04/04/19
Fly Intel: Top five analyst initiations
ACRS Aclaris Therapeutics
$1.87 /

+ (+0.00%)

10/22/19 SVB Leerink
Aclaris Therapeutics upgraded to Outperform from Market Perform at SVB Leerink
10/22/19 SVB Leerink
Aclaris Therapeutics upgraded to Outperform at SVB Leerink
10/22/19 SVB Leerink
Aclaris Therapeutics upgraded to Outperform from Market Perform at SVB Leerink
10/11/19 William Blair
William Blair sees 'significant value disconnect' in Aclaris Therapeutics
MRNA Moderna
$18.39 /

+0.42 (+2.34%)

12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
08/16/19 Piper Sandler
Moderna should be bought ahead of catalysts, says Piper Jaffray
RARE Ultragenyx
$43.64 /

-1.485 (-3.29%)

12/18/19 Piper Sandler
Piper remains buyer of Ultragenyx after Royalty Pharma deal
11/27/19 Cowen
Ultragenyx weakness a buying opportunity, says Cowen
09/04/19 SVB Leerink
Ultragenyx price target raised to $85 from $80 at SVB Leerink
09/04/19 Piper Sandler
Ultragenyx announced positive DTX401 update, says Piper Jaffray
VERO Venus Concept
$5.67 /

+0.76 (+15.48%)

01/09/20 Oppenheimer
Oppenheimer says has 'fundamentally positive' stance on Venus Concept
01/09/20 Maxim
Venus Concept upgraded to Buy from Hold at Maxim
ISRG Intuitive Surgical
$585.69 /

+4.35 (+0.75%)

01/09/20 JPMorgan
Danaher, Thermo named JPMorgan's top 2020 picks in Life Science Tools
01/07/20 Deutsche Bank
Deutsche sees sign Intuitive Surgical's U.S. procedure growth slowed in Q4
12/20/19 Piper Sandler
Intuitive Surgical competition still few years away, says Piper Jaffray
12/16/19 Piper Sandler
Congress could permanently repeal 3 health industry taxes, says Piper Jaffray
KBH KB Home
$37.06 /

+0.06 (+0.16%)

01/07/20 Raymond James
Raymond James upgrades homebuilder sector, makes three stock rating changes
01/07/20 Raymond James
KB Home upgraded to Strong Buy from Outperform at Raymond James
12/27/19 Wedbush
Lower homes supply should support homebuilder pricing power, says Wedbush
12/17/19 RBC Capital
KB Home, Owens Corning, Skyline price targets raised at RBC Capital
PTLA Portola Pharmaceuticals
$24.73 /

+0.74 (+3.08%)

11/08/19 Goldman Sachs
Portola Pharmaceuticals initiated with a Neutral at Goldman Sachs
08/08/19 Citi
The time to buy Portola Pharmaceuticals is now, says Citi
08/05/19
Fly Intel: Top five analyst initiations
08/05/19 Credit Suisse
Portola Pharmaceuticals assumed with a Neutral at Credit Suisse
SPWH Sportsman's Warehouse
$7.97 /

-0.67 (-7.75%)

01/06/20 Lake Street
Sportsman's Warehouse initiated with a Buy at Lake Street
12/12/19 Craig-Hallum
Sportsman's Warehouse initiated with a Buy at Craig-Hallum
12/05/19 Piper Sandler
Sportsman's Warehouse price target raised to $11 from $8 at Piper Jaffray
10/02/19 Piper Sandler
Sportsman's Warehouse price target raised to $8 from $7 at Piper Jaffray
URBN Urban Outfitters
$27.69 /

-0.79 (-2.77%)

12/16/19
Fly Intel: Top five analyst downgrades
12/16/19 Loop Capital
Urban Outfitters downgraded to Hold from Buy at Loop Capital
12/16/19 Loop Capital
Urban Outfitters downgraded to Hold from Buy at Loop Capital
11/20/19 Loop Capital
Urban Outfitters price target lowered to $28 from $35 at Loop Capital
GRUB GrubHub
$55.80 /

+1.1 (+2.01%)

01/09/20 JMP Securities
Uber the most likely buyer if GrubHub gets sold, says JMP Securities
01/09/20 Deutsche Bank
GrubHub could be worth 'substantially higher' in buyout, says Deutsche Bank
01/09/20 Wedbush
GrubHub price target raised to $45 from $30 at Wedbush
01/08/20 Stifel
GrubHub's reported strategic review 'seems prudent,' says Stifel

TODAY'S FREE FLY STORIES

General news
China cut the reverse repo rate by 20 bp » 03:15
03/30/20
03/30
03:15
03/30/20
03:15

China cut the reverse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Asian Market Update: » 03:10
03/30/20
03/30
03:10
03/30/20
03:10

Asian Market Update: U.S.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar has traded steady-to-firmer » 03:05
03/30/20
03/30
03:05
03/30/20
03:05

FX Update: The dollar has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Moderna to host conference call » 22:10
03/29/20
03/29
22:10
03/29/20
22:10
MRNA

Moderna

$30.01 /

+2.1 (+7.52%)

Management holds a…

Management holds a conference call to provide an update on the impact of COVID-19 on business operations and clinical program development on March 30 at 8 am. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Goldman Sachs aerospace/defense analysts hold analyst/industry conference call » 22:03
03/29/20
03/29
22:03
03/29/20
22:03
EADSY

Airbus

$0.00 /

+ (+0.00%)

, BA

Boeing

$162.01 /

-18.155 (-10.08%)

U.S. Aerospace &…

U.S. Aerospace & Defense Analyst Poponak, European Aerospace & Defense Analyst Hallam and Asian Pacific Transportation Analyst Hartwright, discuss Boeing vs Airbus on an Analyst/Industry conference call to be held on March 31 at 5 am. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Goldman Sachs medical tech analyst to hold an analyst/industry conference call » 21:55
03/29/20
03/29
21:55
03/29/20
21:55

Medical Technology…

Medical Technology Analyst Hazan, along with Dr. Guido Gelpi, Cardiovascular Surgeon in Lombardia, Italy and Dr. Leonard Conradi, Cardiothoracic Surgeon at Hamburg University in Germany, provide insights on the COVID-19 impact in Italy and Germany on an Analyst/Industry conference call to be held on March 30 at 11 am. Webcast Link

Conference/Events
Goldman Sachs China commodities analyst to hold analyst/industry conference call » 21:39
03/29/20
03/29
21:39
03/29/20
21:39

China Commodities Analyst…

China Commodities Analyst Trina Chen provides an update on an Analyst/Industry conference call to be held on March 30 at 8 am. Webcast Link

Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 21:32
03/29/20
03/29
21:32
03/29/20
21:32
WIX

Wix.com

$106.47 /

-14.2 (-11.77%)

, GDDY

GoDaddy

$56.84 /

-1.64 (-2.80%)

Software & Internet…

Software & Internet Analyst Thill, along with Craig Meltzer, an expert web developer and IT consultant, discusses the impact on major website building platforms and projects from COVID-19 on an Analyst/Industry conference call to be held on April 3 at 11 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Upland Software participates in a conference call with Jefferies » 21:29
03/29/20
03/29
21:29
03/29/20
21:29
UPLD

Upland Software

$24.51 /

-1.81 (-6.88%)

Software & Internet…

Software & Internet Analyst Thill holds a conference call with Chairman & CEO McDonald and CFO Hill on March 31 at 3 pm hosted by Jefferies.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Raymond James upgrades Amgen to Outperform on limited COVID-19 disruption » 21:06
03/29/20
03/29
21:06
03/29/20
21:06
AMGN

Amgen

$198.49 /

+ (+0.00%)

Raymond James analyst…

Raymond James analyst Dane Leone upgraded Amgen to Outperform from Market Perform with a $255 price target. The company already provided conservative guidance for 2020 during the Q4 earnings call, and disruption from the COVID-19 pandemic should not be outsized relative to Amgen's peers, Leone tells investors in a research note. The analyst believes the GALACTIC-HF study is still likely to read out by the end of 2020 and that the outcome is likely to be positive. Further, the Phase 2 monotherapy study of AMG 510 may support a New Drug Application filing with the FDA for advanced non-small cell lung cancer patients that harbor KRAS G12C mutations, adds the analyst.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Citi downgrades Huazhu on COVID-19 uncertainties after Goldman upgrade » 21:01
03/29/20
03/29
21:01
03/29/20
21:01
HTHT

Huazhu Group

$27.81 /

-2.08 (-6.96%)

Citi analyst Lydia Ling…

Citi analyst Lydia Ling downgraded Huazhu Group to Neutral from Buy with a price target of $30, down from $40. The recovery of the company's China operation could be dampened by its European operation as COVID-19 spreads globally, which raised uncertainties in Q2, Ling tells investors in a research note. The analyst is also concerned that the disruptive impact from COVID-19 on China's hotel sector might not be short term only. Franchisees could be more cautious on hotel openings given pressured operating cash flow, says Ling. Goldman Sachs this morning upgraded Huazhu Group to Buy.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Phillips 66 upgraded to Outperform from Sector Perform at RBC Capital » 20:57
03/29/20
03/29
20:57
03/29/20
20:57
PSX

Phillips 66

$52.29 /

-2.2 (-4.04%)

RBC Capital analyst Brad…

RBC Capital analyst Brad Heffern upgraded Phillips 66 to Outperform from Sector Perform with a price target of $67, down from $73. 2020 is shaping up to be the most dislocated petroleum market in decades, and Phillips 66's "extensive" logistics/marketing network has historically allowed the company to take advantage of dislocations better than anyone else, Heffern tells investors in a research note. The analyst sees Phillips 66 as the only refiner likely to generate "meaningful" positive earnings in 2020. Further, the company's dividend "looks very safe" despite a 7% yield, contends Heffern.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
China Resources Cement upgraded to Neutral from Sell at Goldman Sachs » 20:53
03/29/20
03/29
20:53
03/29/20
20:53
CARCY

China Resources Cement

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Trina Chen upgraded China Resources Cement to Neutral from Sell with an HK$8.90 price target. The analyst sees a more balanced risk/reward profile at the current share price.

Downgrade
CVR Energy downgraded to Underperform with $16 target at Credit Suisse » 20:50
03/29/20
03/29
20:50
03/29/20
20:50
CVI

CVR Energy

$15.16 /

-2.255 (-12.95%)

, DK

Delek US

$13.75 /

-0.28 (-2.00%)

Credit Suisse analyst…

Credit Suisse analyst Manav Gupta downgraded CVR Energy (CVI) to Underperform from Neutral with a price target of $16, down from $40. The analyst believes a CVR Energy - Delek US (DK) deal would take up to six months before finding out if Delek actually ends up selling itself. During this time frame, CVR Energy is likely to underperform, Gupta tells investors in a research note. When looking at the history of M&A in the refining space, the acquirer has always underperformed the group in the time frame from when the deal is announced to the point where the deal actually closes, says the analyst.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Brookfield downgraded to Market Perform from Outperform at Keefe Bruyette » 20:45
03/29/20
03/29
20:45
03/29/20
20:45
BAM

Brookfield

$42.23 /

-1.53 (-3.50%)

Keefe Bruyette analyst…

Keefe Bruyette analyst Robert Lee downgraded Brookfield Asset Management to Market Perform from Outperform.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Hamilton Lane upgraded to Market Perform from Underperform at Keefe Bruyette » 20:38
03/29/20
03/29
20:38
03/29/20
20:38
HLNE

Hamilton Lane

$55.38 /

-1.34 (-2.36%)

Keefe Bruyette analyst…

Keefe Bruyette analyst Robert Lee upgraded Hamilton Lane to Market Perform from Underperform with a $56 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Huazhu Group downgraded to Neutral from Buy at Citi » 20:27
03/29/20
03/29
20:27
03/29/20
20:27
HTHT

Huazhu Group

$27.81 /

-2.08 (-6.96%)

Citi analyst Lydia Ling…

Citi analyst Lydia Ling downgraded Huazhu Group to Neutral from Buy with a price target of $30, down from $40.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Amgen upgraded to Outperform from Market Perform at Raymond James » 20:25
03/29/20
03/29
20:25
03/29/20
20:25
AMGN

Amgen

$198.49 /

+ (+0.00%)

Raymond James analyst…

Raymond James analyst Dane Leone upgraded Amgen to Outperform from Market Perform with a $255 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Cigna, Humana waiving cost-sharing for COVID-19 treatments, Bloomberg says » 20:16
03/29/20
03/29
20:16
03/29/20
20:16
CI

Cigna

$161.03 /

-8.39 (-4.95%)

, HUM

Humana

$297.02 /

-7.99 (-2.62%)

Cigna (CI) and Humana…

Cigna (CI) and Humana (HUM said they will waive out-of-pocket costs for patients who need treatment for COVID-19, Bloomberg's John Tozzi reports. Leaders of both companies called it the right thing to do to help alleviate financial stress for their members and to remove barriers that could keep people from getting needed medical care, the author adds. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
International Paper selling Brazilian corrugated packaging business » 20:13
03/29/20
03/29
20:13
03/29/20
20:13
IP

International Paper

$30.60 /

-0.45 (-1.45%)

International Paper has…

International Paper has entered into an agreement to sell its Brazilian corrugated packaging business to Klabin S.A. for R$330M, with R$280M to be paid at closing and R$50M one year thereafter, subject to certain adjustments. This business includes three containerboard mills and four box plants. This agreement follows International Paper's previously announced strategic review of the Brazil packaging business. The transaction is expected to close in the second half of 2020, subject to certain closing conditions and regulatory approvals. The company will continue to run its Papers and Forestry businesses in Brazil.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
EVO Payments announces $150M investment, suspends FY20 guidance » 20:12
03/29/20
03/29
20:12
03/29/20
20:12
EVOP

EVO Payments

$13.92 /

-1.57 (-10.14%)

EVO Payments announced…

EVO Payments announced that it has received a $150M investment from funds affiliated with Madison Dearborn Partners, a leading private equity firm that has been a significant shareholder of the company since 2012. MDP's added resources will strengthen EVO's financial profile and enable the company to remain focused on future strategic initiatives as it navigates the global COVID-19 pandemic. A portion of the proceeds from MDP's investment will be used to pay down EVO's revolver borrowings, reducing EVO's pro forma leverage ratio as of December 31, 2019 to 3.3-times net debt to Adjusted EBITDA. The remainder of the proceeds are expected to be used to fund potential future investment opportunities. EVO is also closely monitoring COVID-19 and its impact on the company's business. While EVO's global portfolio represents a diversified mix of merchants across Europe and North America, many of these merchants operate in markets that are subject to broad governmental restrictions on movement and commerce, resulting in substantial reductions in merchant transaction count and volumes. In response, EVO has taken significant and necessary steps to align its cost structure and cash flows with the expected near-term decline in revenues caused by COVID-19. These actions include a series of initiatives to reduce fixed costs up to 20% for the remainder of fiscal 2020 and lower capital expenditures by up to 75% over the same period. Such reductions will depend on the pace in which economic activity returns. Given the unknown duration and extent of COVID-19's impact on EVO's business, the company is suspending its 2020 annual guidance published on February 27, 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: Top five weekend stock stories » 19:12
03/29/20
03/29
19:12
03/29/20
19:12
CYH

Community Health

$3.33 /

-0.55 (-14.18%)

, HCA

HCA Healthcare

$87.49 /

-6.98 (-7.39%)

, LPNT

LifePoint

$0.00 /

+ (+0.00%)

, THC

Tenet

$17.06 /

-1.37 (-7.43%)

, UHS

Universal Health

$88.91 /

-3.2 (-3.47%)

, AMZN

Amazon.com

$1,900.79 /

-52.4 (-2.68%)

, MSFT

Microsoft

$149.66 /

-6.35 (-4.07%)

, AAPL

Apple

$247.74 /

-10.74 (-4.16%)

, GOOGL

Alphabet Class A

$1,109.46 /

-53.25 (-4.58%)

, GOOG

Alphabet

$1,110.80 /

-50.63 (-4.36%)

, GM

General Motors

$21.37 /

-1.17 (-5.19%)

, CAT

Caterpillar

$105.20 /

-5.49 (-4.96%)

, MRK

Merck

$71.62 /

-1.77 (-2.41%)

, INTC

Intel

$52.35 /

-3.26 (-5.86%)

, HON

Honeywell

$131.13 /

-6.095 (-4.44%)

, BBY

Best Buy

$62.36 /

-0.69 (-1.09%)

, GWW

Grainger

$246.57 /

+1.17 (+0.48%)

, DHI

D.R. Horton

$36.79 /

-2.58 (-6.55%)

, QCOM

Qualcomm

$66.50 /

-2.48 (-3.60%)

, AKAM

Akamai

$90.45 /

-4.05 (-4.29%)

, LMT

Lockheed Martin

$348.48 /

-1.96 (-0.56%)

, BLK

BlackRock

$434.59 /

-17.24 (-3.82%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. President Donald Trump said on Sunday that he will extend the guidelines aimed at slowing the spread of the coronavirus to April 30, from his original target of Easter on April 12, according to Reuters. Trump added that deaths from the coronavirus could peak around Easter. The President also accused hospitals of hoarding ventilators that are in scarce supply across the U.S. as the coronavirus spreads, adding any hospitals not using the devices must release them, Reuters' Nandita Bose and Phil Stewart reported. Publicly traded companies in the space include Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS). 2. Amazon (AMZN) warehouse workers in Staten Island plan to strike on Monday to call attention to the lack of protections for employees who continue to come to work amid the coronavirus outbreak, CNBC's Annie Palmer reported. Nearly 100 workers at the facility, known as JFK8, plan to participate in the work stoppage, the author notes. The employees will walk out Monday morning and "cease all operations" until their demands are heard by site leadership, said Chris Smalls, a management assistant at JFK8 and a lead organizer of the strike. 3. Microsoft (MSFT), Apple (AAPL), Amazon, and Google parent Alphabet (GOOGL) with their fortress-solid balance sheets, are poised to come out of the downturn just as strong as they went in, Eric Savitz wrote in this week's edition of Barron's. 4. General Motors (GM) agreed to a $120M settlement over faulty ignition switches that allegedly caused cars to stall and air bags to deploy, in some cases triggering fatal accidents, Bloomberg's Robert Burnson reported. The deal, which must be approved by a judge, would resolve hundreds of lawsuits filed before the automaker sought bankruptcy protection in 2009, the author noted. 5. Caterpillar (CAT), Merck (MRK), UnitedHealth, Intel (INTC), Honeywell International (HON), Best Buy (BBY), W.W. Grainger (GWW), D.R. Horton (DHI), Qualcomm (QCOM), Akamai Technologies (AKAM), Lockheed Martin (LMT), and BlackRock (BLK) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Trump extends coronavirus guidelines past Easter to April 30, Reuters says » 18:57
03/29/20
03/29
18:57
03/29/20
18:57
SPY

SPDR S&P 500 ETF Trust

$253.79 /

-7.61 (-2.91%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

President Donald Trump…

President Donald Trump said on Sunday that he will extend the guidelines aimed at slowing the spread of the coronavirus to April 30, from his original target of Easter on April 12, according to Reuters. Trump added that deaths from the coronavirus could peak around Easter. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Trump accuses hospitals of hoarding ventilators, Reuters reports » 18:19
03/29/20
03/29
18:19
03/29/20
18:19
THC

Tenet

$17.06 /

-1.37 (-7.43%)

, UHS

Universal Health

$88.91 /

-3.2 (-3.47%)

, LPNT

LifePoint

$0.00 /

+ (+0.00%)

, CYH

Community Health

$3.33 /

-0.55 (-14.18%)

, HCA

HCA Healthcare

$87.49 /

-6.98 (-7.39%)

President Donald Trump…

President Donald Trump accused hospitals of hoarding ventilators that are in scarce supply across the U.S. as the coronavirus spreads, adding any hospitals not using the devices must release them, Reuters' Nandita Bose and Phil Stewart report. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kirkland Lake Gold says worker at Detour Lake Mine tested positive for COVID-19 » 18:17
03/29/20
03/29
18:17
03/29/20
18:17
KL

Kirkland Lake Gold

$31.99 /

-0.9 (-2.74%)

Kirkland Lake Gold was…

Kirkland Lake Gold was informed on Friday, March 27, 2020 that a worker who had been at Detour Lake Mine earlier this month has tested positive for the COVID-19 virus. The worker arrived at the mine with no symptoms on March 12th, began showing symptoms and self-isolated on March 14th and was taken from site on the morning of March 16th. All protocols were followed while the worker was on site. He received a positive result on Thursday, March 26th and informed the company on Friday, March 27th. All Detour Lake Mine employees were notified upon the company being informed of the positive test on March 27th with instruction to be particularly vigilant in self-monitoring for signs of symptoms, particularly until March 30th. Employees were also instructed to complete the Ontario health self-assessment and to self-isolate and consult medical staff if the results indicated a need to do so. In addition, the company has been informed by public health officials involved in the case, that all persons identified by the worker as having been in close contact have been contacted directly by the Porcupine Health Unit and instructed to seek a medical assessment and to self-isolate if advised to do so. Following a request by the company, the Porcupine Health Unit visited Detour Lake Mine on Saturday, March 28th to review the company's health and safety protocols related to the COVID-19 virus. The company is not aware of any workers at Detour Lake Mine, or at any of its other operations or offices, that are showing symptoms or are in self-isolation at site.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.